Stock Events

Stock Events

UroGen Pharma (URGN) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.97

-0.83

-0.69

-0.55

Details

Expected EPS

-0.817143

Actual EPS

-0.55

Surprise EPS

0.27

Surprise Percent

+32.69%

Description

UroGen Pharma (URGN) has reported earnings of -0.55 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.